Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zori, R. T.
Right arrow Articles by Williams, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zori, R. T.
Right arrow Articles by Williams, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Angelman Syndrome: Clinical Profile

Roberto T. Zori, MD

Raymond C. Philips Research and Education Unit, Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL

Jill Hendrickson, MS

Raymond C. Philips Research and Education Unit, Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL

Sheila Woolven

Angelman Syndrome Support Group, Waterlooville, England

Elaine M. Whidden, MSN, ARNP

Raymond C. Philips Research and Education Unit, Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL

Brian Gray, MS

Raymond C. Philips Research and Education Unit, Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL

Charles A. Williams, MD

Raymond C. Philips Research and Education Unit, Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL

To further delineate the clinical and developmental features of Angelman syndrome, we collected data through three sources of information: (1) physical examinations; (2) laboratory data and family questionnaire data of affected individuals; and (3) literature review. The questionnaire data describes a generally normal prenatal and birth history. Feeding difficulties, developmental delay, or seizures were the presenting problems in all infants. The diagnosis of Angelman syndrome, however, was not made in any infant prior to 1 year of age. Except for seizures, no medical or surgical complication was common, although a variety of visual complaints or findings were common. Sixty percent of Angelman syndrome children had a cytogenetically demonstrated deletion of chromosome 15q11-q13. The individuals with and without a deletion could not be differentiated clinically. Diagnosis in early childhood is therefore difficult, and a high index of suspicion is recommended. (J Child Neurol 1992;7:270-280).

Journal of Child Neurology, Vol. 7, No. 3, 270-280 (1992)
DOI: 10.1177/088307389200700307


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
K. D. Valente, C. P. Koiffmann, C. Fridman, M. Varella, F. Kok, J. Q. Andrade, R. M. Grossmann, and M. J. Marques-Dias
Epilepsy in Patients With Angelman Syndrome Caused by Deletion of the Chromosome 15q11-13
Arch Neurol, January 1, 2006; 63(1): 122 - 128.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. Borgatti, P. Piccinelli, D. Passoni, A. Romeo, M. Viri, S. A. Musumeci, M. Elia, T. Cogliati, D. Valseriati, R. Grasso, et al.
Peripheral Markers of the {gamma}-Aminobutyric Acid (GABA)ergic System in Angelman's Syndrome
J Child Neurol, January 1, 2003; 18(1): 21 - 25.
[Abstract] [PDF]


Home page
J. Med. Genet.Home page
A. Moncla, P. Malzac, M.-O. Livet, M.-A. Voelckel, J. Mancini, J. C. Delaroziere, N. Philip, and J.-F. Mattei
Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling
J. Med. Genet., July 1, 1999; 36(7): 554 - 560.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
M Ruggieri and M A McShane
Parental view of epilepsy in Angelman syndrome: a questionnaire study
Arch. Dis. Child., November 1, 1998; 79(5): 423 - 426.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
F. Viani, A. Romeo, M. Viri, M. Mastrangelo, F. Lalatta, A. Selicorni, G. Gobbi, G. Lanzi, D. Bettio, V. Briscioli, et al.
Seizure and EEG Patterns in Angelman's Syndrome
J Child Neurol, November 1, 1995; 10(6): 467 - 471.
[Abstract] [PDF]